COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 155 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,890,275 | +7.2% | 710,884 | +3.1% | 0.00% | 0.0% |
| Q2 2023 | $14,821,531 | -3.9% | 689,694 | +7.2% | 0.00% | 0.0% |
| Q1 2023 | $15,430,088 | +107366.8% | 643,188 | +3.9% | 0.00% | 0.0% |
| Q4 2022 | $14,358 | -99.9% | 618,917 | +2.2% | 0.00% | +100.0% |
| Q3 2022 | $9,703,000 | -9.2% | 605,692 | +0.4% | 0.00% | -50.0% |
| Q2 2022 | $10,691,000 | -14.0% | 603,386 | -1.2% | 0.00% | 0.0% |
| Q1 2022 | $12,431,000 | +10.0% | 610,605 | +0.9% | 0.00% | +100.0% |
| Q4 2021 | $11,303,000 | -6.2% | 605,137 | -0.9% | 0.00% | -50.0% |
| Q3 2021 | $12,053,000 | -18.1% | 610,593 | -1.9% | 0.00% | 0.0% |
| Q2 2021 | $14,708,000 | +5.9% | 622,202 | +6.1% | 0.00% | 0.0% |
| Q1 2021 | $13,894,000 | +32.0% | 586,275 | +11.5% | 0.00% | 0.0% |
| Q4 2020 | $10,529,000 | -0.1% | 525,688 | +3.9% | 0.00% | 0.0% |
| Q3 2020 | $10,536,000 | +18.5% | 506,061 | -0.4% | 0.00% | 0.0% |
| Q2 2020 | $8,889,000 | +11.6% | 507,963 | +4.1% | 0.00% | 0.0% |
| Q1 2020 | $7,967,000 | -54.5% | 487,908 | -42.6% | 0.00% | 0.0% |
| Q4 2019 | $17,496,000 | +274.2% | 850,286 | +108.7% | 0.00% | +100.0% |
| Q3 2019 | $4,676,000 | -11.7% | 407,345 | +1.1% | 0.00% | 0.0% |
| Q2 2019 | $5,297,000 | -3.6% | 402,884 | +10.9% | 0.00% | 0.0% |
| Q1 2019 | $5,497,000 | -49.6% | 363,136 | -42.8% | 0.00% | -50.0% |
| Q4 2018 | $10,900,000 | +158.5% | 634,898 | +121.9% | 0.00% | +100.0% |
| Q3 2018 | $4,217,000 | -21.9% | 286,148 | +26.4% | 0.00% | -50.0% |
| Q2 2018 | $5,399,000 | +5.0% | 226,405 | +12.5% | 0.00% | 0.0% |
| Q1 2018 | $5,143,000 | +45.4% | 201,309 | +5.0% | 0.00% | +100.0% |
| Q4 2017 | $3,537,000 | +90.5% | 191,634 | +8.2% | 0.00% | 0.0% |
| Q3 2017 | $1,857,000 | -12.9% | 177,045 | +3.9% | 0.00% | 0.0% |
| Q2 2017 | $2,132,000 | +44.6% | 170,469 | +16.3% | 0.00% | 0.0% |
| Q1 2017 | $1,474,000 | -33.2% | 146,568 | +3.4% | 0.00% | 0.0% |
| Q4 2016 | $2,206,000 | +8.5% | 141,702 | +34.2% | 0.00% | 0.0% |
| Q3 2016 | $2,033,000 | +100.9% | 105,569 | +23.6% | 0.00% | 0.0% |
| Q2 2016 | $1,012,000 | -29.3% | 85,421 | +8.3% | 0.00% | 0.0% |
| Q1 2016 | $1,432,000 | +15.5% | 78,903 | +74.9% | 0.00% | 0.0% |
| Q4 2015 | $1,240,000 | +47.8% | 45,120 | +18.8% | 0.00% | 0.0% |
| Q3 2015 | $839,000 | – | 37,987 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tejara Capital Ltd | 289,803 | $6,477,097 | 3.67% |
| Tamarack Advisers, LP | 185,000 | $4,134,750 | 2.68% |
| Rubric Capital Management LP | 3,175,000 | $70,961,250 | 2.66% |
| Eventide Asset Management | 2,631,334 | $58,810,315 | 1.06% |
| Camber Capital Management LP | 1,050,000 | $23,468 | 0.77% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 559,480 | $12,504,378 | 0.76% |
| EMERALD ADVISERS, LLC | 690,487 | $15,432,380 | 0.75% |
| Values First Advisors, Inc. | 43,507 | $972,374 | 0.63% |
| AlphaCentric Advisors LLC | 49,500 | $1,106,325 | 0.63% |
| SummerHaven Investment Management, LLC | 33,666 | $752,435 | 0.55% |